AGL Quote, Financials, Valuation and Earnings

InnovAge Holding has a net margin of -6.95% compared to Agilon Health's net margin of -6.33%. Agilon Health's return on equity of -42.35% beat InnovAge Holding's return on equity of -8.76%.

Agilon Health has a consensus price target of $4.32, signalling upside risk potential of 4.8%. On the other hand InnovAge Holding has an analysts' consensus of $5.25 which suggests that it could grow by 81.66%. Given that InnovAge Holding has higher upside potential than Agilon Health, analysts believe InnovAge Holding is more attractive than Agilon Health.

Agilon Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison InnovAge Holding has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Agilon Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InnovAge Holding offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilon Health pays -- of its earnings as a dividend. InnovAge Holding pays out -- of its earnings as a dividend.

Agilon Health quarterly revenues are $1.5B, which are larger than InnovAge Holding quarterly revenues of $209M. Agilon Health's net income of -$105.8M is lower than InnovAge Holding's net income of -$13.2M. Notably, Agilon Health's price-to-earnings ratio is -- while InnovAge Holding's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health is 0.28x versus 0.49x for InnovAge Holding. Usually stocks with elevated PS ratios are considered overvalued.

LifeStance Health Group has a net margin of -6.95% compared to Agilon Health's net margin of -2.19%. Agilon Health's return on equity of -42.35% beat LifeStance Health Group's return on equity of -4.01%.

Agilon Health has a consensus price target of $4.32, signalling upside risk potential of 4.8%. On the other hand LifeStance Health Group has an analysts' consensus of $9.14 which suggests that it could grow by 38.11%. Given that LifeStance Health Group has higher upside potential than Agilon Health, analysts believe LifeStance Health Group is more attractive than Agilon Health.

Agilon Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LifeStance Health Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Agilon Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LifeStance Health Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilon Health pays -- of its earnings as a dividend. LifeStance Health Group pays out -- of its earnings as a dividend.

Agilon Health quarterly revenues are $1.5B, which are larger than LifeStance Health Group quarterly revenues of $325.5M. Agilon Health's net income of -$105.8M is lower than LifeStance Health Group's net income of -$7.1M. Notably, Agilon Health's price-to-earnings ratio is -- while LifeStance Health Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health is 0.28x versus 2.01x for LifeStance Health Group. Usually stocks with elevated PS ratios are considered overvalued.

National Healthcare has a net margin of -6.95% compared to Agilon Health's net margin of 1.65%. Agilon Health's return on equity of -42.35% beat National Healthcare's return on equity of 10.72%.

Agilon Health has a consensus price target of $4.32, signalling upside risk potential of 4.8%. On the other hand National Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Agilon Health has higher upside potential than National Healthcare, analysts believe Agilon Health is more attractive than National Healthcare.

Agilon Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Healthcare has a beta of 0.512, suggesting its less volatile than the S&P 500 by 48.765%.

Agilon Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Healthcare offers a yield of 2.59% to investors and pays a quarterly dividend of $0.61 per share. Agilon Health pays -- of its earnings as a dividend. National Healthcare pays out 36.27% of its earnings as a dividend. National Healthcare's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilon Health quarterly revenues are $1.5B, which are larger than National Healthcare quarterly revenues of $369.4M. Agilon Health's net income of -$105.8M is lower than National Healthcare's net income of $6.1M. Notably, Agilon Health's price-to-earnings ratio is -- while National Healthcare's PE ratio is 14.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health is 0.28x versus 1.13x for National Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Sonida Senior Living has a net margin of -6.95% compared to Agilon Health's net margin of -5.99%. Agilon Health's return on equity of -42.35% beat Sonida Senior Living's return on equity of -4.58%.

Agilon Health has a consensus price target of $4.32, signalling upside risk potential of 4.8%. On the other hand Sonida Senior Living has an analysts' consensus of $25.00 which suggests that it could grow by 5.49%. Given that Sonida Senior Living has higher upside potential than Agilon Health, analysts believe Sonida Senior Living is more attractive than Agilon Health.

Agilon Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sonida Senior Living has a beta of 1.143, suggesting its more volatile than the S&P 500 by 14.264%.

Agilon Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonida Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilon Health pays -- of its earnings as a dividend. Sonida Senior Living pays out -136.86% of its earnings as a dividend.

Agilon Health quarterly revenues are $1.5B, which are larger than Sonida Senior Living quarterly revenues of $91.9M. Agilon Health's net income of -$105.8M is lower than Sonida Senior Living's net income of -$5.5M. Notably, Agilon Health's price-to-earnings ratio is -- while Sonida Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health is 0.28x versus 1.11x for Sonida Senior Living. Usually stocks with elevated PS ratios are considered overvalued.